RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,191,000 | -47.6% | 388,613 | -33.4% | 0.06% | -39.1% |
| Q2 2019 | $17,555,000 | +282.3% | 583,813 | +184.8% | 0.09% | +338.1% |
| Q1 2019 | $4,592,000 | +323.2% | 205,000 | +244.0% | 0.02% | +320.0% |
| Q4 2018 | $1,085,000 | -23.3% | 59,600 | -23.8% | 0.01% | -16.7% |
| Q3 2018 | $1,415,000 | +66.5% | 78,199 | -21.8% | 0.01% | +50.0% |
| Q4 2017 | $850,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |